Specialty Equity Research and Professional Trading Service

Trades fully vetted with in-depth research based on a 3-pronged approach:
Fundamentals, Technicals and Options Activity

Jaguar 30 Long/Short Index | $88.29 (+0.03%)


Welcome  Jags!

Our mission is to deliver actionable, timely, fundamentally driven equity research to help you outperform the broader market. Our trading is based on a specific, tried-and-true approach that consistently delivers results. Read more about our methods.

You will receive top of the line research and market information, along with specific trade recommendations. Check out the subscription page for more details, and please read a welcome letter from Fahad Khalid, Chief Executive Officer.

For more research notes like these, sign-up for our free weekly newsletter, JaguarResearch.

November 20, 2020 | 1:24 PM by Jay Kunstman

Chicken Soup for the Soul Entertainment (CSSE) – Content Expansion

Chicken Soup for the Soul Entertainment (CSSE) is a $208M operator of streaming video-on-demand networks. As a quick background, back in March 2019, Sony Pictures announced that it sold a…

Continue Reading »

November 13, 2020 | 7:51 AM by Jay Kunstman

Behind The Numbers – fuboTV (FUBO)

fuboTV (FUBO) is a leading virtual multichannel video programming distributor (vMVPD) that offers a sports-first, live-TV streaming platform. fuboTV generates revenue from subscribers through recurring subscription fees and through advertising…

Continue Reading »

November 11, 2020 | 11:37 AM by Jay Kunstman

Cryoport (CYRX) – A Rich Clinical Pipeline

Cryoport (CYRX) is a leading provider of cold chain logistics solutions to the life sciences industry. This will be the third time covering this name on the home page (August…

Continue Reading »

November 7, 2020 | 3:37 PM by Jay Kunstman

Behind The Numbers – Century Casinos (CNTY)

**This Behind The Numbers write-up is one of a handful in tomorrow’s Weekend Research report, sent to Jaguar clients every Sunday. Century Casinos (CNTY) develops and operators gaming establishments, as…

Continue Reading »

November 4, 2020 | 1:56 PM by Jay Kunstman

IPO Watch – Pulmonx (LUNG)

Pulmonx (LUNG), which debuted on October 1st, is a medtech company providing a minimally-invasive treatment for severe emphysema patients. Emphysema is a form of chronic obstructive pulmonary disease, or COPD,…

Continue Reading »

Read more articles
Sign up for a four-week trial!

Password must meet the following requirements: